SCHEMBL81346

SCHEMBL81346

O=c1[nH]sc2cc(O)ccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
MAPT P10636 4/20 0.61
LMNA P02545 3/20 0.61
POLB P06746 1/20 0.61
KDM4E B2RXH2 4/20 0.53
HTT P42858 3/20 0.53
DDAH1 O94760 1/20 0.53
CASP3 P42574 1/20 0.53
CACNA1B Q00975 1/20 0.53
APBA1 Q02410 1/20 0.53
MAOA P21397 3/20 0.46
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
MIF P14174 1/20 0.38
HPGD P15428 2/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
PARP1 P09874 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645428 0.84 MAPT (0.53) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL8130952 0.76 ALDH1A1 (1.00) ALDH1A1MAPTLMNAPOLBKDM4E
Ticlatone SCHEMBL30165586 0.76 ALDH1A1 (0.61) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL5807922 0.76 ALDH1A1 (0.61) ALDH1A1MAPTLMNAPOLBKDM4E
Ticlatone SCHEMBL193888 0.76 ALDH1A1 (0.61) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL13455388 0.76 ALDH1A1 (0.61) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL15680252 0.75 MAOA (0.53) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL11541846 0.73 PARP15 (0.46) ALDH1A1MAPTPOLBKDM4EHTT
SCHEMBL25828724 0.73 ALDH1A1 (0.53) ALDH1A1MAPTLMNAPOLBKDM4E
SCHEMBL25834539 0.73 ALDH1A1 (0.53) ALDH1A1MAPTLMNAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110711496-B Anti-biological-pollution porous membrane and preparation method and application thereof 东莞东阳光科研发有限公司 2022-01-14 CN disclosed
CN-110711496-A Anti-biological-pollution porous membrane and preparation method and application thereof 东莞东阳光科研发有限公司 2020-01-21 CN disclosed
US-9662328-B2 Targeting human thymidylate kinase induces DNA repair toxicity in malignant tumor cells NATIONAL TAIWAN UNIVERSITY (TW) 2017-05-30 US disclosed
US-20160290036-A1 HEAT-SHIELDING MATERIAL AND WINDOW GLASS FUJIFILM CORPORATION (JP) 2016-10-06 US disclosed
US-20160290036-A1 HEAT-SHIELDING MATERIAL AND WINDOW GLASS FUJIFILM CORPORATION (JP) 2016-10-06 US disclosed
US-20160151362-A1 TARGETING HUMAN THYMIDYLATE KINASE INDUCES DNA REPAIR TOXICITY IN MALIGNANT TUMOR CELLS NATIONAL TAIWAN UNIVERSITY (TW) 2016-06-02 US disclosed
US-8129308-B2 Thermal transfer image-receiving sheet and surface condition improver FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
US-8129308-B2 Thermal transfer image-receiving sheet and surface condition improver FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
US-20090087552-A1 METHOD OF PRODUCING HEAT-SENSITIVE TRANSFER IMAGE-RECEIVING SHEET FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087552-A1 METHOD OF PRODUCING HEAT-SENSITIVE TRANSFER IMAGE-RECEIVING SHEET FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
EP-2042334-A2 Method of producing heat-sensitive transfer image-receiving sheet Fujifilm Corporation (JP) 2009-04-01 EP disclosed
US-20090011154-A1 THERMAL TRANSFER IMAGE-RECEIVING SHEET AND SURFACE CONDITION IMPROVER FUJIFILM CORPORATION (JP) 2009-01-08 US disclosed
US-20090011154-A1 THERMAL TRANSFER IMAGE-RECEIVING SHEET AND SURFACE CONDITION IMPROVER FUJIFILM CORPORATION (JP) 2009-01-08 US disclosed
EP-1974946-A1 Thermal transfer image-receiving sheet and surface condition improver FUJIFILM Corporation (JP) 2008-10-01 EP disclosed
EP-0235449-B1 HERBICIDAL SULFONAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-09-11 EP disclosed
EP-0235449-A1 Herbicidal sulfonamides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1987-09-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160151362-A1 TARGETING HUMAN THYMIDYLATE KINASE INDUCES DNA REPAIR TOXICITY IN MALIGNANT TUMOR CELLS DTYMK, TYMP, TK1 ALDH1A1 1743/4885MAPT 2559/4885LMNA 4164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.